Skip to main content

Table 3 Evaluation of variables at cardiac magnetic resonance

From: The role of left atrio-ventricular coupling index and left atrial ejection fraction in predicting onset of atrial fibrillation and adverse cardiac events in hypertrophic cardiomyopathy

 

Total (n = 141)

HCM-AF (n = 35)

HCM no-AF (n = 106)

P value

LVEDV (± sd)

128 (28.1)

125.6 (34.8)

128.8 (25.8)

0.64

LVESV (± sd)

40 (12.2)

38 (12.6)

41.2 (12)

0.27

LVEF (± sd)

68.5 (7.2)

69.4 (9.7)

68.2 (6.2)

0.15

LVthick(± sd)

19.3 (4.8)

20 (5.6)

19 (4.5)

0.36

LAVmax (± sd)

93.2 (26.8)

109 (25.7)

59.5 (13.5)

0.001*

LAVImax (± sd)

50.9 (13.9)

69.5 (21.5)

50.5 (17.4)

< 0.001*

LAA

25.3 (8)

30.7 (7.4)

23.8 (7.7)

0.06

LAVmin (± sd)

55.4 (20.2)

69,5 (21.5)

50.5 (17.4)

< 0.001*

LAVImin(± sd)

30.3 (10.9)

37.6 (11.9)

27.7 (9.5)

< 0.001*

LAEF(± sd)

40 (9.4)

35 (10.3)

42 (8.3)

0.001*

LACI(± sd)

44 (16)

57 (17)

40 (13)

< 0.001*

LVmass (± sd)

158.9 (64.7)

163.7 (80.7)

157.4 (58.9)

0.68

LGE in gr (± sd)

13.2 (20.7)

15.9 (23.3)

12.4 (20)

0.21

LGE in % (± sd)

8.8 (14)

10.3 (13.3)

8.4 (14.3)

0.23

  1. LAA left atrium area, LACI left atrioventricular coupling index, LAD left atrium diameter, LAEF left atrium ejection fraction, LAV max maximal left atrium volume, LAV min minimal left atrium volume, LAVI max indexed maximal left atrium volume, LAVI min indexed minimal left atrium volume, LGE in gr late gadolinium enhancement in grams, LGE in % late gadolinium enhancement in percentage, LVEDV left ventricular end-diastolic volume, LVEF left ventricular ejection fraction, LVESV left ventricular end-systolic volume, LV mass left ventricular mass
  2. *p values correspond to statistically significant result with p < 0.05